Gene and Cell Therapy for Rare & Common Diseases

Gene therapy is a superior method to treat uncommon hereditary maladies; fix a solitary quality deformity by presenting a 'right' quality. The main quality treatment preliminaries were directed utilizing patients with uncommon monogenetic issue, however these are presently dwarfed by the clinical testing of quality therapeutics for more typical conditions, for example, malignancy, AIDS and cardiovascular illness. This is halfway because of an inability to accomplish long haul quality articulation with early vector frameworks, a basic prerequisite for amending numerous innate hereditary deformities. Presently, with the appearance of adeno-related viral (AAV) and lent viral vectors, which show steady quality articulation in creature thinks about, this mechanical obstruction, may have been survived. These vectors are foreseen to shape the premise of numerous gene therapy protocols for acquired hereditary illnesses.

 

  • Neurological Disorder
  • Wound Healing
  • Cancer
  • Cardiovascular Disorder
  • Orthopedic Repair
  • Blindness Vision Impairment
  • HIV

Related Conference of Gene and Cell Therapy for Rare & Common Diseases

November 21-22, 2024

11th World Congress on Epigenetics and Chromosome

Dubai, UAE
December 09-10, 2024

17th World Congress on Stem Cell Research

Dubai, UAE
March 17-18, 2025

8th Global Conference on Cell and Gene Therapy

Paris, France
June 16-17, 2025

21st Global Summit on Stem Cell & Regenerative Medicine

Frankfurt, Germany

Gene and Cell Therapy for Rare & Common Diseases Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in